Shuai Wang

19PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)BiomaterialsBiomolecular modelling and designNanofabrication, growth and self assemblyBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 09, 2026
AI-Optimized 3D-Printed Dual-Layer Implant: Resolving Chemo-Immunotherapy Sequential Administration Dilemma for Colorectal Cancer Peritoneal Metastasis.

|Jun 26, 2026
Mesoporous Catalytic-Adsorptive Nanoregulator Orchestrates Biofilm eDNA/LPS Disassembly and TLR9/TLR4 Immune Reprogramming to Resolve Diabetic Foot Infections.

|Mar 30, 2026
Rational Design of Broad-Spectrum Non-Nucleoside Reverse Transcriptase Inhibitors via Pharmacophore-Oriented Generative Artificial Intelligence.

Kun Zhang, Yuhan Lin, Ling Dong

|Jan 23, 2026
Tailoring Square-Shaped 2D Mesoporous Nanosheets via an Interface-Confined Anisotropic Assembly Strategy.

Minchao Liu, Hongyue Yu, Yufang Kou

|Jan 09, 2026
Cyclization-Inspired Structural Optimization: Designing Potent Non-nucleoside Reverse Transcriptase Inhibitors with Enhanced Safety and Selectivity.

Yin-Xiang Zhang, Christophe Pannecouque, Erik De Clercq

|Aug 14, 2025
Halogenation-Driven Discovery of Halomethylene-Biphenyl-Diarylpyrimidines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Improved Safety and PK Profiles.

Xiao-Mei Chen, Qian Xu, Christophe Pannecouque

Pageof 4

Frequent Collaborators

13 joint publications

Fener Chen

12 joint publications

Erik De Clercq

5 joint publications

Angela Corona

4 joint publications

Tiancong Zhao